Floatz logo

Sodium Thiosulfate

Recurrent Desmoplastic Small Round Cell Tumor

Mayo ClinicSmall moleculeEarly Phase 1Dormant
C
39/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
24/ 100
Competitive Position
95/ 100

Competitive context

10 Active assets in the Recurrent Desmoplastic Small Round Cell Tumor cohort.

Asset / SponsorPhaseRating
Cyclophosphamide
St. Jude Children's Research Hospital
Phase 2B
Fludarabine
St. Jude Children's Research Hospital
Phase 2B
Imatinib
National Cancer Institute (NCI)
Phase 2B
Evomela
M.D. Anderson Cancer Center
Phase 2CCC
ETOPOSIDE
M.D. Anderson Cancer Center
Phase 2CCC

View all 30 →

Same molecule, other indications

Sodium Thiosulfate is also rated in:

central nervous system neoplasmDormant
BB
Indicative ·
70 / 100
View asset →
sarcomaDormant
BB
Indicative ·
65 / 100
View asset →
Epithelial Ovarian CancerDormant
B
Indicative ·
62 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →